THERALASE TECHNOLOGIES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.165 CAD | +6.45% |
|
0.00% | -5.71% |
| 04-24 | Theralase Technologies Inc. announced that it has received CAD 0.7502 million in funding | CI |
| 04-05 | Theralase Technologies Inc. Receives Canadian Cancer Vaccine Patent | CI |
Evolution of the average Target Price on Theralase Technologies Inc.
Price target over the last 5 years
History of analyst recommendation changes
e44fe4dcc2c798db22a4a1bcb8ab576._oD6A3oofj8hyybDCdgr4CIdpM9C4S3Zcp2h3Wul06w.qsSMewJDN1lsn2OgbZVT2EBu1JAwo2ShIs_VjxL3kd24ys1pLGQNYGeyQQ~637ffea762ace8e89cf9d73aa535773a
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.165
CAD
Average target price
0.8
CAD
Spread / Average Target
+384.85%
High Price Target
0.8
CAD
Spread / Highest target
+384.85%
Low Price Target
0.8
CAD
Spread / Lowest Target
+384.85%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- TLT Stock
- Consensus Theralase Technologies Inc.
